Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy.
Zhou Y, Wang S, Tao Y, Chen H, Qin Y, He X, Zhou S, Liu P, Yang J, Yang S, Gui L, Lou N, Zhang Z, Yao J, Han X, Shi Y.
Zhou Y, et al. Among authors: chen h.
J Transl Med. 2021 Sep 20;19(1):399. doi: 10.1186/s12967-021-03078-9.
J Transl Med. 2021.
PMID: 34544443
Free PMC article.